Furthermore, gestational diabetes, Clopidogrel resistance131, and glycaemic response to glucagon-like peptide-1 analogue therapy in type 2 diabetes mellitus are each associated with three of the four dmCpGs in VTRNA2-1132. This evidence concerns the gene GCG and diabetes mellitus.